Iran J Vet Surg, Print ISSN: 2008-3033, Online ISSN: 2676-6299

Document Type : Original Article


Department of Clinical Science, Faculty of Specialized Veterinary Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.


The aim of this study was conducted to identify the short-term effects of ovariohysterectomy on the heart of immature cats using echocardiography. This longitudinal study was conducted on a sample consisting of 6 immature female DSH cats. After the selection of test items, echocardiography was performed on the cats before the ovariohysterectomy (D0) and ten days (D10), twenty days (D20), and thirty days (D30) after the ovariohysterectomy. Cardiac parameters, including fractional shortening (FS), ejection fraction (EF), cardiac output (CO), left atrial-to-aortic root diameter ratio (LA/Ao), and left ventricular wall thickness to interventricular septum ratio (LVWD/IVS) was measured. Results indicated that the average EF at D10 (71.83%), D20 (71.00%), and D30 (69.83%) was significantly reduced compared to D0 (77.66%). The average CO at D10 (1.68 l/min), D20 (1.51 l/min), and D30 (1.5 l/min) was significantly reduced compared to D0 (2.05 l/min). However, the average FS at D10 (40.54%), D20 (40.50%), and D30 (39.33%) reduced compared to D0 (45.00%); the reduction was not statistically significant. The average Ao/LA and LVPW/IVS remained unchanged during the study (without noticeable changes). Ovariohysterectomy negatively impacts cardiac function; accordingly, special care and follow-up during sterility are essential for maintaining cardiac health.


Main Subjects

  1. Root Kustriz M. Determination the optimal age for gonadectomy of dogs and cats. Journal of the American Veterinary Medical Association. 2007; 231: 1665-1675.
  2. Egenvall A, Bonnett BN, Ohagen P. Incidence of and survival after mammary tumors in a population of over 80.000 insured female dogs in sweden from 1995 to 2002. Preventive Veterinary Medicine. 2005; 69: 109-127.
  3. Salmeri KR, Bloomberg MS, Scruggs SL, Shille V. Gonadectomy in immature dogs: effects on skeletal, physical, and behavioral development. Journal of the American Veterinary Medical Association. 1991; 1193–1203.
  4. Marmor M. Willeberg P, Glickman LA, Priester W, Cypess RH, Hurvitz A. Epizootiologic patterns of diabetes mellitus in dogs. American Journal of Veterinary Research. 1982; 43: 465–470.
  5. De Leo V, D’Antona D, Lanzetta D. Thyrotropin secretion before and after ovariectomy in premenopausal women. Gynecological Endocrinology. 1993; 7: 279–283.
  6. Rissetto K, Villamil JA, Selting KA. Recent trands in feline intestinal neoplasia: an epidemiologic study of cases in the veterinary medical database from 1964 to 2004. Journal of the American Animal Hospital Association. 2011; 47: 28-36.
  7. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Annals of Internal Medicine. 1976; 85: 447-452.
  8. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease: the Framingham study. Annals of Internal Medicine. 1978; 89: 157-161.
  9. Knowlton A, Lee A. Estrogen and the cardiovascular system. Pharmacology and Therapeutics. 2012; 135: 54-70.
  10. Shen L, Song L, Liu B, Li H, Zheng X, Zhang L, Yuan J, Liang Y, Wang Y. Effects of early age at natural menopause on coronary heart disease and stroke in Chinese women. International Journal of Cardiology. 2017; 241: 6-11.
  11. Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang Y-F. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke. 2001; 32: 1104-1111.
  12. Matthews KA, Wing RR, Kuller LH, Meilahn EN, Plantinga P. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Archives of Internal Medicine. 1994; 154: 2349-2355.
  13. Sutton-Tyrrell K, Wildman RP, Matthews KA, Chae C, Lasley BL, Brockwell S, Pasternak RC, Lloyd-Jones D, Sowers MF, Torréns JI. Sex hormone–binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation. 2005; 111: 1242-1249.
  14. Oskui PM, French WJ, Herring MJ, Mayeda GS, Burstein S, Kloner RA. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. Journal of the American Heart Association. 2013; 2(6): 272.
  15. Subramanya V, Zhao DI, Ouyang P, Lima JA, Vaidya D, Ndumele CE, Bluemke DA, Shah SJ, Guallar E, Nwabuo CC, Allison MA. Sex hormone levels and change in left ventricular structure among men and post-menopausal women: the Multi-Ethnic Study of Atherosclerosis (MESA). Maturitas. 2018; 108: 37-44.
  16. Xing D, Nozell S, Chen YF, Hage F, Oparil S. Estrogen and mechanisms of vascar protection. Arteriosclerosis, Thrombosis, and Vascular Biology. 2009; 29(3): 289–295.
  17. Deschamps AM, Murphy E, Sun J. Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends in Cardiovascular Medicine. 2010; 20(3): 73–78.
  18. Korzick D, Lancaster T. Age-related differences in cardiac ischemia–reperfusion injury: effects of estrogen deficiency. Pflugers Archiv European Journal of Physiology. 2013; 465(5): 669–685.
  19. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019; 139: 56–528.
  20. Muka, C Oliver-Williams, S Kunutsor. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiology. 2016; 767-776.
  21. Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, Brunner EJ, Kuh D, Hardy R, Avis NE, Gold EB. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. The Lancet Public Health. 2019; 4(11): 553-564.
  22. De Kat AC, Dam V, Onland-Moret NC, Eijkemans MJ, Broekmans FJ, Van Der Schouw YT. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Medicine. 2017; 15(1): 1.
  23. Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas, 2006; 53(2): 226-233.
  24. Dam V, Van Der Schouw YT, Onland-Moret NC, Groenwold RH, Peters SA, Burgess S, Butterworth A. Association of menopausal characteristics and risk of coronary heart disease: a pan-European case–cohort analysis. International Journal of Epidemiology. 2019; 48(4): 1275-1285.‏
  25. Reethega L, Devi RG, Priya AJ. A survey on prevalence of heart diseases in women after menopause. Drug Invention Today. 2018; 10.‏
  26. Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD. American Heart Association Prevention Science Committee of the Council on Epidemiology and Prevention; and Council on Cardiovascular and Stroke Nursing. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020; 142(25): 506-532.
  27. Duzenli MA, Ozdemir K, Sokmen A, Gezginc K, Soylu A, Celik C, Altunkeser BB, Tokac M. The effects of hormone replacement therapy on myocardial performance in early postmenopausal women. Climacteric. 2010; 13: 157–170.
  28. Duzenli MA, Ozdemir K, Sokmen A, Soylu A, Aygul N, Gezginc K, Tokac M. Effects of menopause on the myocardial velocities and myocardial performance index. Circulation Journal. 2007; 71: 1728–1733.
  29. Kaur M, Singh H, Ahuja GK. Cardiac performance in relation to age of onset of menopause. The Journal of the Indian Medical Association. 2011; 109: 234–237.
  30. Rahman I, Åkesson A, Wolk A. Relationship between age at natural menopause and risk of heart failure. Menopause. 2015; 22(1): 12-16.
  31. Ruiz-Ortega M, Lorenzo O, Rupérez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension. 2001; 38(6): 1382-1387.
  32. Zhao Z, Wang H, Jessup JA, Lindsey SH, Chappell MC, Groban L. Role of estrogen in diastolic dysfunction. American Journal of Physiology-Heart and Circulatory Physiology. 2014; 306(5): H628-H640.
  33. Rocca WA, Shuster LT, Grossardt BR, Maraganore DM, Gostout BS, Geda YE, Melton III LJ. Long-term effects of bilateral oophorectomy on brain aging: unanswered questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging. Women’s Health. 2009; 5(1): 39-48.
  34. Zhoa Di, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, Lima JA, Allison MA, Shah SJ, Bertoni AG, Budoff MJ, Post WS, Erin B. Endogenous Sex hormones and incident cardiovascular disease in post-menopausal women. Journal of the American College of Cardiology. 2018; 71: 2555-2566.
  35. Dosi R, Bhatt N, Shah P, Patell R. Cardiovascular disease and menopause. Journal of Clinical and Diagnostic Research. 2014; 8(2): 62.‏
  36. Ingelsson E, Lundholm C, Johansson AL, Altman D. Hysterectomy and risk of cardiovascular disease: a population-based cohort study. European Heart Journal. 2011; 32(6), 745-750.
  37. Abbas SZ, Sangawan V, Das A, Pandey AK. Assessment of cardiovascular risk in natural and surgical menopause. Indian Journal of Endocrinology and Metabolism. 2018; 22(2) :223-228.